EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing the potential for non-digestible carbohydrates toward mitigating adverse effects of antibiotics on microbiota composition and activity in an in vitro colon model of the weaning infant

Martha F Endika iD, David J M Barnett, Emiliana M Olmos, Cajo J F Ter Braak, Ilja C W Arts, John Penders, Arjen Nauta, Hans Leemhuis, Koen Venema, Hauke Smidt iD

FEMS Microbiology Ecology · 2025

DOI: 10.1093/femsec/fiaf028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEMS Microbiology Ecology, 2025. Verfasst von Martha F Endika und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiology, Wageningen University & Research, 6708 PE Wageningen, The Netherlands. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Colon, Gastrointestinal Microbiome, Dietary Carbohydrates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carbohydrate Competence Center, Dutch Research Council, FrieslandCampina.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Environmental factors like diet and antibiotics modulate the gut microbiota in early life. During weaning, gut microbiota progressively diversifies through exposure to non-digestible carbohydrates (NDCs) from diet, while antibiotic perturbations might disrupt this process. Supplementing an infant’s diet with prebiotic NDCs may mitigate the adverse effects of antibiotics on gut microbiota development. This study evaluated the influence of supplementation with 2-fucosyllactose (2′-FL), galacto-oligosaccharides (GOS), or isomalto/malto-polysaccharides containing 87% of α(1→6) linkages (IMMP-87), on the recovery of antibiotic-perturbed microbiota. The TIM-2 in vitro colon model inoculated with fecal microbiota of 9-month-old infants was used to simulate the colon of weaning infants exposed to the antibiotics amoxicillin/clavulanate or azithromycin. Both antibiotics induced changes in microbiota composition, with no signs of recovery in azithromycin-treated microbiota within 72 h. Moreover, antibiotic exposure affected microbiota activity, indicated by a low valerate production, and azithromycin treatment was associated with increased succinate production. The IMMP-87 supplementation promoted the compositional recovery of amoxicillin/clavulanate-perturbed microbiota, associated with the recovery of Ruminococcus, Ruminococcus gauvreauii group, and Holdemanella. NDC supplementation did not influence compositional recovery of azithromycin-treated microbiota. Irrespective of antibiotic exposure, supplementation with 2′-FL, GOS, or IMMP-87 enhanced microbiota activity by increasing short-chain fatty acids production (acetate, propionate, and butyrate).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsColonGastrointestinal MicrobiomeDietary CarbohydratesHumansInfantFecesPrebioticsWeaningAzithromycinAmoxicillin-Potassium Clavulanate CombinationOligosaccharidesTrisaccharidesBacteriaFatty Acids, Volatile

Stichwörter der Autor:innen

2′-FLGOSIMMPamoxicillin/clavulanateazithromycingut bacteria

Substanzen

Anti-Bacterial AgentsPrebioticsAzithromycinAmoxicillin-Potassium Clavulanate CombinationOligosaccharidesTrisaccharides2'-fucosyllactoseDietary CarbohydratesFatty Acids, Volatile

Autor:innen und Institutionen

  • Laboratory of Microbiology, Wageningen University & Research, 6708 PE Wageningen, The Netherlands.
  • Maastricht Centre for Systems Biology (MaCSBio), Maastricht University, 6229 EN Maastricht, The Netherlands.
  • School for Nutrition and Translational Research in Metabolism, Department of Medical Microbiology, Infection Prevention and Infectious Diseases, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands.
  • Biometris, Wageningen University & Research, 6708 PB Wageningen, The Netherlands.
  • FrieslandCampina, 3818 LE Amersfoort, The Netherlands.
  • Avebe Innovation Center, 9747 AA Groningen, The Netherlands.

ORCID-Profile: Martha F Endika, Hauke Smidt

Förderung

  • Carbohydrate Competence Center
  • Dutch Research Council
  • FrieslandCampina

Zitieren

APA

Endika, M. F., Barnett, D. J. M., Olmos, E. M., Ter Braak, C. J. F., Arts, I. C. W., Penders, J., Nauta, A., Leemhuis, H., Venema, K., & Smidt, H. (2025). Assessing the potential for non-digestible carbohydrates toward mitigating adverse effects of antibiotics on microbiota composition and activity in an in vitro colon model of the weaning infant. FEMS Microbiology Ecology. https://doi.org/10.1093/femsec/fiaf028

Vancouver

Endika MF, Barnett DJM, Olmos EM, Ter Braak CJF, Arts ICW, Penders J, et al. Assessing the potential for non-digestible carbohydrates toward mitigating adverse effects of antibiotics on microbiota composition and activity in an in vitro colon model of the weaning infant. FEMS Microbiology Ecology. 2025. doi:10.1093/femsec/fiaf028

BibTeX
@article{Endika2025,
  author = {Endika, Martha F and Barnett, David J M and Olmos, Emiliana M and Ter Braak, Cajo J F and Arts, Ilja C W and Penders, John and Nauta, Arjen and Leemhuis, Hans and Venema, Koen and Smidt, Hauke},
  title = {Assessing the potential for non-digestible carbohydrates toward mitigating adverse effects of antibiotics on microbiota composition and activity in an in vitro colon model of the weaning infant},
  journal = {FEMS Microbiology Ecology},
  year = {2025},
  doi = {10.1093/femsec/fiaf028}
}
Kostenlos starten →